The Latest Breaking News from Pfizer

While inflation has been showing signs of cooling recently, it is still far beyond the Fed’s target rate. Consequently, the Fed is expected to keep raising the interest rates for some time, fueling the chances of a global recession. Therefore, it could be wise to invest in well-performing stocks Pfizer…

Big pharma has money to make and the covid vaccine is fertile ground for revenue. But at least one U.S. politician is urging caution.

Stock futures slip lower on hawkish Fed signals; Powell speech in focus as rate bets test tightening path; Pfizer may sell Covid treatment in China through local partner; Oak Street Health soars on $10 billion CVS takeover report and Microsoft said to eye $10 billion OpenAI investment.

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive

Social media users shared a range of false claims this week

Policymakers are now squarely focused on reviving the economy. But some analysts warned against ‘excessive optimism’ about when pre-pandemic growth rates will return

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…